Repository of Research and Investigative Information

Repository of Research and Investigative Information

Shahid Sadoughi University of Medical Sciences

Items where Author is "Mirshafiey, Abbas"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 12.

(2020) Efficacy of β-D-Mannuronic Acid M2000 on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC. Current drug discovery technologies. pp. 225-232.

(2019) Vitamin D downregulates key genes of diabetes complications in cardiomyocyte. Journal of cellular physiology. pp. 21352-21358. ISSN 1097-4652

(2019) Vitamin D suppresses cellular pathways of diabetes complication in liver. Iranian journal of basic medical sciences. pp. 690-694. ISSN 2008-3866

(2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology. ISSN 1568-5608

(2018) Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties. Immunologic research. ISSN 1559-0755

(2018) Efficacy of β-D-mannuronic acid [M2000] on pro-apoptotic process and inflammatory related molecules NFҡB, IL-8 and Cd49d using healthy donor PBMC. Current drug discovery technologies. ISSN 1875-6220

(2018) Effect of β-D-mannuronic acid (M2000) on oxidative stress enzymes' gene using healthy donor peripheral blood mononuclear cells for evaluating the anti-aging property. Current drug discovery technologies. ISSN 1875-6220

(2018) Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. pp. 495-500. ISSN 1950-6007

(2018) Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial. International immunopharmacology. pp. 112-117. ISSN 1878-1705

(2017) Introduction of β-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression. Pharmacological Reports.

(2015) The signal transducer and activator of transcription factors lodge in immunopathogenesis of rheumatoid arthritis. Reumatismo. pp. 127-137.

(2014) Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Medical Journal. pp. 185-189.

This list was generated on Wed Mar 12 19:04:46 2025 +0330.